S19-279 Nanoparticles Containing Toll-Like Receptor Agonist for Enhanced Efficacy of Immune Checkpoint Blockade Stanford inventors have developed a nanoparticle containing the toll-like receptor agonist (TLR7-NP) that elicits a potent anti-tumor immune response in multiple cancer types without inducing undesired systemic inflammation and toxicity. Qian Yin Mark Davis
S08-441 Oligocarbonate molecular transporters across biological barriers Stanford University researchers have developed a new family of oligocarbonate molecular transporters (OMTs) that penetrate cell membranes and tissues. Paul Wender Robert Waymouth James Hedrick Fredrik Nederberg Christina Cooley Brian Trantow Matthew Kiesewetter